NDC 17033-451 - Clavacillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-451
- Package NDCs from labels
- 17033-451-15
- Manufacturer
- Dechra Veterinary Products, LLC
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clavacillin - Dechra Veterinary Products, LLC | Dechra Veterinary Products, LLC | 2026-04-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17033-451-15 | Clavacillin | 15 mL in 1 VIAL, GLASS | POWDER, FOR SUSPENSION | 15 | 5 | |
| 17033-451-15 | Clavacillin | 1 in 1 CARTON | POWDER, FOR SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amoxicillin and clavulanate potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Devatis, Inc. | b0b2e164-e70d-471f-92ce-abdac6cb405f | 2025-03-10 | Warnings, Adverse reactions | 617322 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | American Health Packaging | ecb439f7-434a-4e4c-b899-943d83346f09 | 2025-03-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | c8030539-314f-437d-abe7-415d6e58add7 | 2025-03-01 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Hikma Pharmaceuticals USA Inc. | 240bcdcb-31d9-40a0-87e1-bd16264a2e20 | 2025-02-28 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Hikma Pharmaceuticals USA Inc. | 6339bcdb-060f-4558-9f42-6bf7f935e138 | 2025-02-28 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | a0822381-ba9a-4f80-bc4f-608301d07fd8 | 2025-02-27 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | cf707c13-3b40-079c-e053-2995a90a2176 | 2025-02-10 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | f9b4d263-bc5b-6065-e053-6394a90a5e35 | 2025-02-10 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 80a04b8a-110e-0aea-e053-2a91aa0ad057 | 2025-02-06 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals, Inc. | 4f1c940c-9f17-4289-e054-00144ff88e88 | 2025-02-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Advanced Rx Pharmacy of Tennessee, LLC | f601c634-2271-2fcd-e053-2995a90aaaba | 2025-02-02 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Advanced Rx Pharmacy of Tennessee, LLC | d294e4a2-8ce7-418d-e053-2a95a90ab10b | 2025-02-02 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | PD-Rx Pharmaceuticals, Inc. | 05b9b595-05d9-469f-82a3-c2bc94c50be2 | 2025-01-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Redpharm Drug | fc61c9f5-b0f8-3ff8-e053-6394a90adeb7 | 2025-01-23 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin/Clav Pot Oral Susp | AMOXICILLIN/CLAV POT ORAL SUSP | Direct_Rx | e5bd9918-b073-c50b-e053-2a95a90aaeb7 | 2025-01-22 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxil | AMOXICILLIN ORAL SUSP | DirectRx | ec7dd735-dc92-3d29-e053-2a95a90af549 | 2025-01-22 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Direct_Rx | f98c49a3-e6bb-7fc7-e053-6394a90a9062 | 2025-01-22 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | DirectRx | cdc6d30a-754e-6672-e053-2a95a90afa7f | 2025-01-20 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| AMOXICILLIN | AMOXICILLIN | DirectRx | cedde8f5-aadd-53de-e053-2995a90aab16 | 2025-01-20 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 2bb03d3b-5d44-bc4a-e063-6394a90a656a | 2025-01-14 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.